AU1825895A - Retroviral vaccines, vaccination and immune-therapy for retroviral infections - Google Patents

Retroviral vaccines, vaccination and immune-therapy for retroviral infections

Info

Publication number
AU1825895A
AU1825895A AU18258/95A AU1825895A AU1825895A AU 1825895 A AU1825895 A AU 1825895A AU 18258/95 A AU18258/95 A AU 18258/95A AU 1825895 A AU1825895 A AU 1825895A AU 1825895 A AU1825895 A AU 1825895A
Authority
AU
Australia
Prior art keywords
retroviral
vaccination
immune
therapy
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18258/95A
Inventor
W. Huppes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smit V
Original Assignee
SMIT V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SMIT V filed Critical SMIT V
Publication of AU1825895A publication Critical patent/AU1825895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU18258/95A 1994-03-11 1995-03-09 Retroviral vaccines, vaccination and immune-therapy for retroviral infections Abandoned AU1825895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL9400384 1994-03-11
NL9400384A NL9400384A (en) 1994-03-11 1994-03-11 Retrovirus vaccines, vaccination and immunotherapy against retroviral infections.
PCT/NL1995/000091 WO1995024215A1 (en) 1994-03-11 1995-03-09 Retroviral vaccines, vaccination and immune-therapy for retroviral infections

Publications (1)

Publication Number Publication Date
AU1825895A true AU1825895A (en) 1995-09-25

Family

ID=19863933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18258/95A Abandoned AU1825895A (en) 1994-03-11 1995-03-09 Retroviral vaccines, vaccination and immune-therapy for retroviral infections

Country Status (3)

Country Link
AU (1) AU1825895A (en)
NL (1) NL9400384A (en)
WO (1) WO1995024215A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
JP4307841B2 (en) 2001-03-22 2009-08-05 アメリカ合衆国 Glycosylation resistant cyanovirin and related conjugates, compositions, nucleic acids, vectors, host cells, methods of making and using non-glycosylated cyanovirins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
DE68918867T2 (en) * 1988-09-13 1995-02-16 Chiron Corp Mutants of the hiv-1 coat protein with missing hypervariable domains.

Also Published As

Publication number Publication date
WO1995024215A1 (en) 1995-09-14
NL9400384A (en) 1995-10-02

Similar Documents

Publication Publication Date Title
AU3150295A (en) Dna vaccines against rotavirus infections
AU4781297A (en) Vaccines
AU9623898A (en) Vaccines
AU1308495A (en) Influenza vaccine
AU5478396A (en) in ovo vaccination against coccidiosis
AU694872B2 (en) in ovo vaccination against coccidiosis
AU2623795A (en) Immunogenic pharmaceuticals
AU3154395A (en) Contraceptive vaccine
AU4460497A (en) Mycosis vaccines
AU2769595A (en) Contraceptive vaccine
AU6820796A (en) Antigenic preparations
AU4450696A (en) Enhanced immunogenic vaccine
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
AU3694795A (en) Novel oligomers, process for their preparation and methods for their use
AU2539697A (en) Anti-idiotypic antibody vaccines
AU3552797A (en) Vaccine preparations
AU1538895A (en) Anti-allergic vaccine
AU5091898A (en) Method of vaccinating infants against infections
AU6736998A (en) Fiv vaccine
AU6075498A (en) Vaccines
AU3930895A (en) Viral preparations, immunogens, and vaccines
IL115197A (en) Vaccine preparations for preventing vaginal infections
AU1740197A (en) Vaccine against hantavirus
AU1716295A (en) Selective virus culture
AU6409894A (en) Recognin vaccines